Key questions about DRd for transplant-ineligible patients with multiple myeloma

Categories / tags

^© Janssen-Cilag NV 2021. This site is published by Janssen-Cilag NV which is solely responsible for its content. It is intended for Healthcare professionals in Belgium and Luxembourg.

Cookie Settings